Nvidia Corp (NVDA) stock surges on role in AI development and adapting to Chinese market, CEO meets with TSMC executives to address supply constraints.
Colorado lawmakers have introduced a bipartisan bill that aims to remove a rule requiring cannabis products to be tested for a fungus called Aspergillus. The rule, which was implemented by the Colorado Marijuana Enforcement Division, resulted in 17 product recalls in 2023, the most in the last seven years. The bill, Senate Bill 24-076, also seeks to make other changes to cannabis business regulations in the state. It would address the issue of labelling mandates for THC-infused products made from remediated marijuana, allow dispensaries to sell consumable goods that don't contain THC or CBD, and extend cannabis licensure from one to two years without any changes in fees. The bill has been brought by the Marijuana Industry Group, which says it is time for Colorado to streamline its regulations, following the lead of states including Nevada, California, Oregon and Maryland.
Historic milestone in healthcare: 21.3M Americans enroll in Obamacare, a 31% increase from last year. Act now, open enrollment persists in select states until January 31.
The Securities and Exchange Commission (SEC) has postponed the deadline for passing a judgment on the proposed spot Ethereum (CRYPTO: ETH) exchange-traded fund by BlackRock Inc (NYSE: BLK)